Literature DB >> 6338024

Interleukin 2: biology and biochemistry.

S Gillis.   

Abstract

Since its discovery as a T-cell growth factor, interleukin 2 (IL-2) has attracted considerable scientific attention, not only as a useful reagent for the maintenance of large numbers of effector T lymphocytes but as a potentially potent immunoregulatory molecule, which could be of therapeutic usefulness in a number of clinical conditions. Outlined in this communication is a summary of the more salient biochemical features of murine and human IL-2, as well as the results of initial molecular biology experimentation aimed at the eventual production of IL-2 by recombinant DNA methodologies. These studies, together with those detailing the in vivo effectiveness of IL-2 therapy in a number of murine model situations, provide a current glimpse of future IL-2 aims and directions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338024     DOI: 10.1007/bf00919133

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  35 in total

1.  Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors.

Authors: 
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

2.  T-cell growth factor-mediated T-cell proliferation.

Authors:  K A Smith; S Gillis; P E Baker; D McKenzie; F W Ruscetti
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

3.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

6.  Translation of lymphocyte mRNA into biologically-active Interleukin 2 in oocytes.

Authors:  R C Bleackley; B Caplan; C Havele; R G Ritzel; T R Mosmann; J J Farrar; V Paetkau
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  Biochemical separation of interleukin 2.

Authors:  D Y Mochizuki; J Watson; S Gillis
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  Two distinct factors are required for induction of T-cell growth.

Authors:  E L Larsson; N N Iscove; A Coutinho
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

9.  Monoclonal cytolytic T-cell lines.

Authors:  P E Baker; S Gillis; K A Smith
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  28 in total

1.  Interleukin-2-like activity in injured rat brain.

Authors:  M Nieto-Sampedro; K G Chandy
Journal:  Neurochem Res       Date:  1987-08       Impact factor: 3.996

2.  Immune function in chronic active Epstein-Barr virus infection.

Authors:  R Kibler; D O Lucas; M J Hicks; B T Poulos; J F Jones
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

3.  Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

Authors:  R Pahwa; T Chatila; S Pahwa; C Paradise; N K Day; R Geha; S A Schwartz; H Slade; N Oyaizu; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.

Authors:  C A Ottaway
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

5.  The effects of interleukins and other soluble factors on T-lymphocyte colony formation.

Authors:  A Winkelstein; P L Simon; D Wood; L L Machen; R K Shadduck; A Waheed
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

6.  Interleukin 2 inhibitor in synovial fluid.

Authors:  P Emery; K C Gentry; A Kelso; I R Mackay
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

7.  Effects of cyclosporine in experimental cryptococcal meningitis.

Authors:  J R Perfect; D T Durack
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  In vitro activation of natural killer-like cytotoxicity by specifically in vivo primed T-helper lymphocytes in the rat.

Authors:  V Britten; R A Robins; R W Baldwin
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

9.  Is lower ploidy of megakaryocytes another reason for uremic thrombocytopathy?

Authors:  M Winkelmann; U Dorr; P Pfitzer; W Schneider
Journal:  Klin Wochenschr       Date:  1986-06-16

10.  Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.

Authors:  E Kedar; E Chriqui-Zeira; S Mitelman
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.